Compare RKDA & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKDA | IMCC |
|---|---|---|
| Founded | 2002 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1M | 1.0M |
| IPO Year | 2015 | 2019 |
| Metric | RKDA | IMCC |
|---|---|---|
| Price | $0.43 | $1.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 144.8K | ★ 871.3K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,858,000.00 | N/A |
| Revenue This Year | $61.67 | $63.88 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $0.09 |
| 52 Week High | $6.71 | $4.15 |
| Indicator | RKDA | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 37.02 | 55.60 |
| Support Level | $0.38 | $1.33 |
| Resistance Level | $0.55 | $2.08 |
| Average True Range (ATR) | 0.04 | 0.33 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 11.75 | 40.72 |
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.